http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1174870_PMID25462281

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369612_AID1174870_PMID25462281_VALUE16
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369606_AID1174870_PMID25462281_VALUE10
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369614_AID1174870_PMID25462281_VALUE18
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103399375_AID1174870_PMID25462281_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103221520_AID1174870_PMID25462281_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369605_AID1174870_PMID25462281_VALUE9
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369609_AID1174870_PMID25462281_VALUE13
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID123083185_AID1174870_PMID25462281_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369608_AID1174870_PMID25462281_VALUE12
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369604_AID1174870_PMID25462281_VALUE8
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369610_AID1174870_PMID25462281_VALUE14
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369613_AID1174870_PMID25462281_VALUE17
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369600_AID1174870_PMID25462281_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369602_AID1174870_PMID25462281_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369611_AID1174870_PMID25462281_VALUE15
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369603_AID1174870_PMID25462281_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369601_AID1174870_PMID25462281_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312369607_AID1174870_PMID25462281_VALUE11
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03181
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Agonist activity at human GAL4-PPARdelta ligand binding domain expressed in human HepG2 cells assessed as maximum fold induction by luciferase reporter gene assay relative to rosiglitazone
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103399375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID123083185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103221520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369609
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312369608
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1174870

Total number of triples: 41.